Related Experiment Videos
Cancer chemotherapy as it approaches middle age
Cancer Chemotherapy and Pharmacology
|January 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical strategy for the development of angiogenesis inhibitors.
The oncologist·2000
Clinical research and drug development of antivirals in HIV: an industry perspective.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1995
Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.
NCI monographs : a publication of the National Cancer Institute·1988
Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1987
Calibrated phase II clinical trials in oncology.
Statistics in medicine·1986
Intensification versus combination: revisiting the past and envisioning the future of LDHA inhibitors.
Cancer chemotherapy and pharmacology·2026
Circulatory compromise as a potential mechanism of fatal hepatic failure during long-term selpercatinib therapy: pharmacokinetic and clinical insights.
Cancer chemotherapy and pharmacology·2026
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.
Cancer chemotherapy and pharmacology·2026
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.
Cancer chemotherapy and pharmacology·2026
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.
Cancer chemotherapy and pharmacology·2026